Kourous A. Rezaei, M.D., is an internationally recognized expert in the treatment of medical and surgical vitreoretinal diseases. He is Associate Professor of Ophthalmology and Director of vitreoretinal fellowship at Rush University Medical Center. Dr. Rezaei is a senior partner at the Illinois Retina Associates in Chicago. He is the founder of ChannelR (www.channelr.net) and course director of RETINAWS and Formula Retina. Dr. Rezaei is a distinguished inductee of the Retina Hall of Fame and is listed in the Illinois Top Doctors. He is on the Board of Retina World Congress, serving as President Elect and is on the organizing committee of the Florence Retina Congress (FLORetina), one of the largest retina meetings in the world. He has served as editorial board member for Investigative Ophthalmology and Visual Science (IOVS), Retina Times (ASRS), Retina Today (BMC), and Eyetube. 

Peter Campochiaro is a clinician-scientist who is the Eccles Professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins University School of Medicine. He studies ocular neovascularization and excessive vascular leakage which occurs in age-related macular degeneration, diabetic retinopathy, and retinal vein occlusion. He utilized mouse models to help define the molecular pathogenesis of ocular neovascularization and excessive vascular leakage, including the roles of VEGF, HIF-1, and Tie2. His clinical trial group showed the benefits of inhibiting VEGF in diabetic macular edema and retinal vein occlusions. He has helped to develop strategies to provide sustained suppression of VEGF that are currently being evaluated in clinical trials. His laboratory also demonstrated that oxidative damage contributes to cone cell death in retinitis pigmentosa and this has also advanced to testing in clinical trials.

Ramin Tadayoni, MD, PhD, is Professor of Ophthalmology at the University of Paris, and Department Chairman at Lariboisière, Saint Louis and Rothschild Foundation Hospitals, Paris, France. He is also the leader of French government funded RHU EviRed research program on artificial intelligence for diabetic retinopathy. He is a EURETINA board member, past President of the French-speaking Retina Specialists Club, and since 2017 elected as member of the French “Académie Nationale de Chirurgie”.

His main areas of interest include retinal diseases, vitreoretinal surgery, and imaging. He is the author of over 170 peer-reviewed medical and scientific articles and has made numerous contributions to ophthalmology textbooks. He has been an invited lecturer for many society meetings and was awarded the American Academy of Ophthalmology Achievement Award in 2010.

Professor Tadayoni was graduated as medical doctor and ophthalmologist from Paris V University. He completed his vitreoretinal fellowship at Lariboisière University Hospital, Paris. He also pursued his PhD at Paris VII University, and Paris Vision Institute. He was later awarded HDR, the highest academic degree in France. He is very committed to education and has the honour of having trained several clinical vitreoretinal and research fellows.